Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/153502
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorAndrés-León, Eduardoes_ES
dc.contributor.authorCases, Ildefonsoes_ES
dc.contributor.authorAlonso, Sergioes_ES
dc.contributor.authorRojas Mendoza, Ana M.es_ES
dc.date.accessioned2017-07-25T11:28:42Z-
dc.date.available2017-07-25T11:28:42Z-
dc.date.issued2017-04-07-
dc.identifier.citationScientific Reports 7: 46101 (2017)es_ES
dc.identifier.issn2045-2322-
dc.identifier.urihttp://hdl.handle.net/10261/153502-
dc.description.abstractCancer is a complex disease in which unrestrained cell proliferation results in tumour development. Extensive research into the molecular mechanisms underlying tumorigenesis has led to the characterization of oncogenes and tumour suppressors that are key elements in cancer growth and progression, as well as that of other important elements like microRNAs. These genes and miRNAs appear to be constitutively deregulated in cancer. To identify signatures of miRNA-mRNA interactions potentially conserved in essential cancer pathways, we have conducted an integrative analysis of transcriptomic data, also taking into account methylation and copy number alterations. We analysed 18,605 raw transcriptome samples from The Cancer Genome Atlas covering 15 of the most common types of human tumours. From this global transcriptome study, we recovered known cancer-associated miRNA-targets and importantly, we identified new potential targets from miRNA families, also analysing the phenotypic outcomes of these genes/mRNAs in terms of survival. Further analyses could lead to novel approaches in cancer therapy.es_ES
dc.description.sponsorshipE.A.-L. was partially funded by the European Commission grant [FP7-REGPOT-2012-2013-1].es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/203953es_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rightsopenAccesses_ES
dc.titleNovel miRNA-mRNA interactions conserved in essential cancer pathwayses_ES
dc.typeartículoes_ES
dc.identifier.doi10.1038/srep46101-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://doi.org/10.1038/srep46101es_ES
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0/es_ES
dc.contributor.funderEuropean Commissiones_ES
dc.relation.csices_ES
oprm.item.hasRevisionno ko 0 false*
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.pmid28387377-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.fulltextWith Fulltext-
item.openairetypeartículo-
Aparece en las colecciones: (IPBLN) Artículos
(IBIS) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
srep46101.pdf1,42 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

18
checked on 28-feb-2024

SCOPUSTM   
Citations

44
checked on 09-abr-2024

WEB OF SCIENCETM
Citations

45
checked on 26-feb-2024

Page view(s)

333
checked on 14-abr-2024

Download(s)

272
checked on 14-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons